C5 Antibodies

Santa Cruz Biotechnology features a diverse variety of C5 monoclonal antibodies for advanced research in immunology and complement system studies. C5 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C5, a crucial component of the complement system, plays a significant role in the immune response by promoting inflammation and facilitating the lysis of pathogens. Its activation leads to the generation of C5a, a potent anaphylatoxin that recruits immune cells to sites of infection, and C5b, which initiates the formation of the membrane attack complex. Understanding C5 function is essential for elucidating mechanisms of immune regulation and developing therapeutic strategies for complement-related diseases. C5 monoclonal antibodies enable precise detection and quantification of C5 protein expression levels across various experimental conditions. Researchers can track C5 activation and distribution in different tissue types and cellular compartments. C5 monoclonal antibodies support detailed investigation of complement cascade dynamics and regulation. Santa Cruz Biotechnology monoclonal antibodies for C5 research empower scientists to advance our understanding of complement-mediated immunity and disease processes.